Intravenous and Subcutaneous Immunoglobulin Therapy
Intravenous Immunoglobulin Therapy (IVIG) is used to help treat immune system disorders. It is infused intermittently every 3-8 weeks depending on the disease state and response to therapy.
- IV access required
- Administered utilizing an infusion pump
- Home health nurse will visit patient to ensure IV access as well as monitor patient throughout the infusion. RN will adjust the rate based on patient response to infusion.
- No first dosing at home
Indications/Candidates for Intravenous Immunoglobulin Therapy
- CVID (Common Variable Immunodeficiency)
- Chronic Inflammatory demyelinating polyneuropathy (CIDP)
- Primary immunodeficiency disorders
Subcutaneous Immunoglobulin Therapy (ScIG) is an Immunoglobulin that is administered under the skin. It is administered intermittently every 1-4 weeks depending on the medication and MD orders.
- No IV access required
- Multiple access sites may be required
- Administered using an infusion pump
- Home Health nurse is required for initial teaching, after which patient can self-infuse.
- Local site reactions can be expected.
- No first dosing at home if Nieve to IG therapy.
Indications/Candidates for Subcutaneous Immunoglobulin Therapy (ScIG)
- Primary humoral immunodeficiency (PI) in adults
- Hizentra and Gammagard can be utilized in patients 2 years of age or older.